#BGS Morningstar Quantitative Ratings
Valuation Rating = Undervalued
Fair Value Estimate = 0.370
Fair Value Percentage Diff= 45.95%
Liquidity = High
- Forums
- ASX - By Stock
- FFX
- Ann: Goulamina ESIA Report Submitted for Approval
Ann: Goulamina ESIA Report Submitted for Approval, page-9
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online